Talaris Therapeutics, Inc. - Common Stock (NQ:TALS)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 19, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Talaris Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

How Is The Market Feeling About Talaris Therapeutics? ↗

October 20, 2022

Talaris Therapeutics's (NASDAQ:TALS) short percent of float has fallen 10.89% since its last report. The company recently reported that it has 527 thousand shares sold short, which is 2.21% of all...

Via Benzinga

Talaris Therapeutics Reports Patient Death In Late-Stage Trial Of Experimental Drug For Graft vs Host Disease ↗

October 20, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗

October 20, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

Dow Surges Over 150 Points; Initial Jobless Claims Drop Last Week ↗

October 20, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 20, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.

Via Benzinga

Around $3 Million Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Buying ↗

August 03, 2022

U.S. crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Talaris Therapeutics And 3 Other Stocks Under $5 Insiders Are Aggressively Buying ↗

July 27, 2022

US crude oil futures traded higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗

July 27, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

Crude Oil Drops 1%; General Motors Earnings Miss Views ↗

July 26, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday.

Via Benzinga

Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings ↗

July 26, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday.

Via Benzinga

Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday ↗

July 06, 2022

Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 05, 2022

Via Benzinga

Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session ↗

July 05, 2022

Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022 ↗

July 05, 2022

Upgrades

Via Benzinga

What 4 Analyst Ratings Have To Say About Talaris Therapeutics ↗

July 05, 2022

Analysts have provided the following ratings for Talaris Therapeutics (NASDAQ:TALS) within the last quarter:

Via Benzinga

Stocks Sporting Muted Losses as Third Quarter Kicks Off ↗

July 01, 2022

The major indexes continue to languish below breakeven as the third quarter gets underway.

Via Talk Markets

U.S Stocks Turn Lower; Dow Tumbles Over 100 Points ↗

July 01, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022 ↗

July 01, 2022

Upgrades

Via Benzinga

Netflix To $210? Here's The Biggest Price Target Changes For Friday ↗

July 01, 2022

Piper Sandler cut The Goldman Sachs Group, Inc. (NYSE: GS) price target from $430 to $410. Goldman Sachs shares fell 0.1% to $296.79 in pre-market trading.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

Talaris Therapeutics Reveals COVID-19 Outcomes Among Kidney Transplant Patients Treated With FCR001 ↗

April 07, 2022

Talaris Therapeutics Inc (NASDAQ: TALS)

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 18, 2022

Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.

Via Benzinga

65 Biggest Movers From Yesterday ↗

December 21, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.